Explore Stanford technologies available for licensing:

Stanford researchers have developed a Data-driven Urban Energy Benchmarking (DUE-B) methodology that uses readily available building energy consumption data to help municipalities design and develop energy efficiency policies and programs.

Stanford researchers at The Lee Lab have discovered a novel epidermal tumor suppressor to treat squamous cell carcinoma (SCC) by utilizing existing drug therapies.

Stanford researchers at the Moore Lab have developed an algorithm for on-line, real time post processing of large amounts of neuronal data from high-density, multi-channel electrophysiological recordings to identify which neurons were firing (on-line spike recovery).

Stanford researchers have developed an architecture and control scheme for the coordination of distributed energy resources (DER), such as solar and storage, to minimize operation cost, enhance network reliability, and provide DER aggregation.

Stanford researchers have created a highly stretchable organic semiconductor by blending high mobility semiconducting polymers with an elastomer.

Patients with celiac disease have a pathological reaction to gluten and have either HLA-DQ2+ (90%) or HLA-DQ8+, but expression of these MHC class II haplotypes is not sufficient and other factors are necessary for the development of celiac sprue.

Ion channel dysfunctions lead to a wide array of illnesses including epilepsy, cardiac arrhythmia and type II diabetes. However, the number of clinically approved drugs for restoring normal ion channel function is limited.

Researchers at Stanford have developed a new methodology for image processing that allows for high-throughput characterization of organoid phenotypes.

Stanford researchers have used deep learning to create a radiotherapy treatment plan verification algorithm. Patient specific dose verification is traditionally done by checking the dose in a patient-mimicking phantom or by using an independent dose calculation algorithm.

Researchers at Stanford have developed a low-cost and rapidly scalable emergency use ventilator for the COVID-19 crisis.

Stanford researchers in the Brongersma Lab have developed an integrated dynamic flat-optics system as part of a comprehensive optofluidic platform, enabling unprecedented compact configurations.

Stanford scientists in Prof. Steven Boxer's lab have invented a quantum cascade laser (QCL)-based IR spectrometer and assay for the sensitive detection of drug-protein interactions in live cells.

The ascending somatosensory pathway transmits sensory information, including pain, touch and itch, from the peripheral nervous system to the brain. Dysfunctions in this pathway are linked to disorders like peripheral neuropathy and autism spectrum disorder.

Stanford researchers have developed a label-free assay to detect protein aggregation and established a proof of concept in α-synuclein aggregates.

Drs.